KYMR
Price
$45.95
Change
-$2.69 (-5.53%)
Updated
Nov 14 closing price
97 days until earnings call
NUVL
Price
$90.18
Change
-$0.16 (-0.18%)
Updated
Nov 14 closing price
137 days until earnings call
Ad is loading...

KYMR vs NUVL

Header iconKYMR vs NUVL Comparison
Open Charts KYMR vs NUVLBanner chart's image
Kymera Therapeutics
Price$45.95
Change-$2.69 (-5.53%)
Volume$413.69K
CapitalizationN/A
Nuvalent
Price$90.18
Change-$0.16 (-0.18%)
Volume$452.52K
CapitalizationN/A
KYMR vs NUVL Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
KYMR vs. NUVL commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongSell and NUVL is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (KYMR: $45.94 vs. NUVL: $90.18)
Brand notoriety: KYMR and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 100% vs. NUVL: 77%
Market capitalization -- KYMR: $2.98B vs. NUVL: $6.36B
KYMR [@Biotechnology] is valued at $2.98B. NUVL’s [@Biotechnology] market capitalization is $6.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and NUVL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while NUVL’s TA Score has 3 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 7 bearish.
  • NUVL’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, both KYMR and NUVL are a bad buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а -7.85% price change this week, while NUVL (@Biotechnology) price change was -4.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.06%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was +6.14%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 20, 2025.

NUVL is expected to report earnings on Apr 01, 2025.

Industries' Descriptions

@Biotechnology (-2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($6.36B) has a higher market cap than KYMR($2.98B). KYMR YTD gains are higher at: 80.460 vs. NUVL (22.544). KYMR has higher annual earnings (EBITDA): -160.96M vs. NUVL (-202.96M). NUVL has more cash in the bank: 658M vs. KYMR (550M). KYMR has higher revenues than NUVL: KYMR (87.6M) vs NUVL (0).
KYMRNUVLKYMR / NUVL
Capitalization2.98B6.36B47%
EBITDA-160.96M-202.96M79%
Gain YTD80.46022.544357%
P/E RatioN/AN/A-
Revenue87.6M0-
Total Cash550M658M84%
Total Debt88.2MN/A-
TECHNICAL ANALYSIS
Technical Analysis
KYMRNUVL
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHCB21.21-0.02
-0.10%
JHancock Corporate Bond ETF
EIS70.70-0.17
-0.24%
iShares MSCI Israel ETF
EAOK25.79-0.07
-0.27%
iShares ESG Aware Conservative Allc ETF
VAW205.52-1.40
-0.68%
Vanguard Materials ETF
FSMD43.10-0.50
-1.15%
Fidelity Small-Mid Multifactor ETF

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with ABCZF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.18%
ABCZF - NUVL
51%
Loosely correlated
N/A
ASND - NUVL
41%
Loosely correlated
-1.39%
NCNA - NUVL
41%
Loosely correlated
-1.90%
IDYA - NUVL
40%
Loosely correlated
-3.35%
KYMR - NUVL
38%
Loosely correlated
-5.52%
More